Transplant Genomics has announced a collaboration with the Mayo Clinic to develop, validate, and commercialize diagnostic tests enabling personalized immunosuppression for solid organ transplant recipients. As part of the multiyear collaboration, Mayo Clinic will make an investment in Transplant Genomics for an undisclosed amount.
Additionally, both companies with work together on co-development of new tests and technologies for additional targets, including exploratory studies in heart and liver transplantation.
Physicians and researchers are participating at Mayo Clinic campuses in Arizona, Florida and Rochester, Minnesota. Principal investigators include: Mark Stegall, M.D., Raymond Heilman, M.D., and Martin Mai, M.D., Mayo Clinic Transplant Center. Continue reading
You have the power to SAVE Lives
Please register as an organ, eye and tissue donor today.
Donate LIFE California | Done VIDA California
Organ Donor | Donate Life America
...to ensure donation happens, please share your donation decision with your family. At stake is the legacy you plan to leave.